STTK - shattucklabs.com Qarzning balans kapitallashuviga nisbati

Shattuck Labs (STTK) grafik logotipi

Shattuck Labs, Inc. (STTK) saraton bilan kurashda immun aktivatsiyasi uchun zamonaviy platformalarni ishlab chiqadi. Umumiy qarzdorlikning kitob kapitalizatsiyasiga nisbati grafigi qiymat 0.01 darajasida qolganini ko'rsatmoqda. Bifunksional oqsillar uchun patentlar uzoq muddatli monopoliyani kafolatlab, barqaror daromad generatorini yaratadi. Biroq, biznes muvaffaqiyati onkologik dori vositalarining klinik sinovlari natijalariga va tadqiqot va ishlanmalar (R&D) xarajatlarining qat'iy nazoratiga bog'liq.

STTK (Shattuck Labs) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 27.10.2026gacha
shattucklabs.com asosiy tovari

Ushbu ko'rsatkich moliyaviy leveraj va to'lov qobiliyatini baholash uchun umumiy majburiyatlarni kapitalga solishtiradi. Mazkur metrika defolt xavfi va qarzga olingan mablag'larning samaradorligi o'rtasidagi muvozanatni belgilaydi. Qarzning kapitalga nisbati ko'rsatkichining tarixiy tendentsiyasi Shattuck Labs, Inc. (STTK) kompaniyasi qimmat onkologik tadqiqotlarni olib borayotgan vaqtda uning moliyaviy barqarorligini aks ettiradi. Institutsional investorlarning Taylor Schreiber jamoasiga bo'lgan ishonchi ushbu nisbatni optimallashtirish imkonini beradi. Ushbu ko'rsatkichning barqarorligi biotexnologiya kompaniyasi rivojlanish strategiyasining ishonchliligini tasdiqlaydi.

Shattuck Labs, Inc. kimlar bilan raqobatlashadi

Balans kapitallashuviga qarzlar ARGX (argenx SE)|biontech.de - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati ABIVAX (ABVX)|ADMA: Qarzning sof aktivlarga nisbati|PTGX (Protagonist Therapeutics Inc) - Qarzning balans kapitallashuviga nisbati|Immunovant Therapeutics (IMVT) - Qarzning balans qiymatiga nisbati|KNSA (Kiniksa Pharmaceuticals) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar grifols.com (GRFS)|Adaptive Biotechnologies Corporation (ADPT) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Celldex Therapeutics Inc (CLDX)|Balans kapitallashuviga qarzlar AUPH|BioCryst Corp - Sof aktivlarga qarzlar|VERA: Qarzning balans kapitallashuviga nisbati|DNTH: Qarzning balans qiymatiga nisbati|PHVS (Pharvaris) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati AbCellera Bio|TRML (Tourmaline Corp) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PGEN|Qarzning balans kapitallashuviga nisbati Pharming Group N.V. PHAR|Qarzning balans qiymatiga nisbati nektar.com (NKTR)|UPB: Balans kapitallashuviga qarzlar|Zenas Bio - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati IMNM (Immunome Corp)|GOSS - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar KalVista Pharmaceuticals KALV|septerna.com (SEPN) - Qarzning sof aktivlarga nisbati|PVLA (Pieris Pharmaceuticals, Inc.) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Savara Inc (SVRA)|Qarzning balans qiymatiga nisbati Rigel Pharmaceuticals Inc|Qarzning balans kapitaliga nisbati AnaptysBio Inc. ANAB|Qarzning balans qiymatiga nisbati Astria Therapeutics (ATXS)|ENGN - Qarzning balans kapitaliga nisbati|RAPT Therapeutics, Inc. - Qarzning balans qiymatiga nisbati|JBIO - Balans kapitallashuviga qarzlar|ACRS (Aclaris) - Balans kapitallashuviga qarzlar|KYTX (Kyverna Therapeutics, Inc) - Qarzning balans qiymatiga nisbati|TLSA (Tiziana Life Sciences) - Qarzning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar cabalettabio.com (CABA)|Ventyx Biosciences, Inc. (VTYX) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati THTX (Theratechnologies, Inc.)|Qarzning balans kapitallashuviga nisbati Avalo Therapeutics Inc. AVTX|Qarzning balans kapitallashuviga nisbati Eledon Pharmaceuticals, Inc ELDN|Agenus - Balans kapitallashuviga qarzlar|CLYM - Balans kapitallashuviga qarzlar|Zura Bio Limited (ZURA) - Balans kapitallashuviga qarzlar|ATYR (aTyr Pharma Inc) - Qarzning balans kapitallashuviga nisbati|ADAG: Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Ikena Oncology, Inc. (IMA)|Equillium, Inc. (EQ) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati connectbiopharm.com (CNTB)|Balans kapitallashuviga qarzlar IMUX|Atara Biotherapeutics, Inc. - Sof aktivlarga qarzlar|InflaRx GmbH (IFRX) - Qarzning balans kapitallashuviga nisbati|XFOR - Qarzning balans qiymatiga nisbati|ACET (adicetbio.com) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Celularity|INMB: Qarzning balans qiymatiga nisbati|Sof aktivlarga qarzlar BRNS|KZR (Kezar Life Sciences, Inc) - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar SAB Biotherapeutics Inc SABS|Qarzning balans qiymatiga nisbati Akari Therapeutics (AKTX)|ENLV - Qarzning balans kapitaliga nisbati|Qarzning balans qiymatiga nisbati Q32 Bio Corp QTTB|GOVX: Qarzning balans kapitaliga nisbati|EDSA: Qarzning balans kapitallashuviga nisbati|IBIO (iBio Corporation) - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Carisma Therapeutics Inc CARM|Qarzlarning balans kapitallashuviga nisbati xtlbio.com|Bolt Biotherapeutics (BOLT) - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati hcwbiologics.com (HCWB)|Balans kapitallashuviga qarzlar APVO (Aptevo Therapeutics Inc.)|AIM ImmunoTech, Inc. - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Aditxt Corp (ADTX)|GRI: Qarzning sof aktivlarga nisbati|XRTX (XORTX Therapeutics) - Qarzning balans kapitallashuviga nisbati|Vyome Holdings Inc. (HIND) - Qarzning balans qiymatiga nisbati|REVB (Revelation Bio) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Indaptus Corp (INDP)|Scinai Immunotherapeutics (SCNI) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati calcimedica.com (CALI)|Balans kapitallashuviga qarzlar AFMD|Allakos Inc - Sof aktivlarga qarzlar|HOOK: Qarzning balans kapitallashuviga nisbati|IGMS: Qarzning balans qiymatiga nisbati|ITOS (iTeos Therapeutics) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati oceanbiomedical.com|TCBP (TC BioPharm) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar THRD